BTN3A3/BTF3, His, Human
BTN3A3/BTF3, His, Human

The purity of BTN3A3/BTF3, His, Human is greater than 95% as determined by SEC-HPLC.

BTN3A3/BTF3, His, Human

BTN3A3/BTF3, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

BTN3A3/BTF3, His, Human

The butyrophilin (BTN) family has many members with diverse functions related to immunomodulation, initiation and progression of tumors. BTN3A3 belongs to the BTN family, and exploring its expression and correlation with the prognosis of non-small cell lung cancer (NSCLC) patients has great clinical significance.The expression of BTN3A3 in NSCLC tissues was significantly lower than in adjacent tissues, and patients with low expression of BTN3A3 had late clinical stages and lower degree of tumor differentiation.
Z05099
¥63,425.00

Ask us a question
Product Introduction
Species Human
Protein Construction
BTN3A3/BTF3 (Gln30-Trp248)
Accession # O00478-1		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 24.7 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • BTN3A3/BTF3, His, Human
    • BTN3A3/BTF3, His, Human

    The purity of BTN3A3/BTF3, His, Human is greater than 95% as determined by SEC-HPLC.

  • BTN3A3/BTF3, His, Human
    • BTN3A3/BTF3, His, Human

    BTN3A3/BTF3, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The butyrophilin (BTN) family has many members with diverse functions related to immunomodulation, initiation and progression of tumors. BTN3A3 belongs to the BTN family, and exploring its expression and correlation with the prognosis of non-small cell lung cancer (NSCLC) patients has great clinical significance.The expression of BTN3A3 in NSCLC tissues was significantly lower than in adjacent tissues, and patients with low expression of BTN3A3 had late clinical stages and lower degree of tumor differentiation.
Synonyms BTN3A3; BTF3; BTN3.3; BTF3butyrophilin 3

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.